Measuring therapy adherence in Parkinson's disease: a comparison of methods
- 1 February 2006
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 77 (2), 249-251
- https://doi.org/10.1136/jnnp.2005.064709
Abstract
The objective of this study was to assess different methods of measuring therapy adherence in Parkinson’s disease (PD). In a single centre observational study, 112 patients with idiopathic PD were randomised to a crossover trial of active monitoring (n = 69, simple tablet count and electronic monitoring), or to no monitoring (n = 43, control group). All patients completed a self report and visual analogue scale (VAS) indicating therapy intake. In the active monitoring group, 56 (81% of cases) used ⩾80% of their medication, and 13 (19% of cases) used <80%, based on electronic monitoring. Median adherence for self report was 100% (interquartile range (IQR) 100 to 100) and for VAS was 100% (IQR 95 to 100), in both active and control groups. Patients taking ⩾80% of prescribed medication had a median total adherence of 98% (IQR 93 to 101) by electronic monitoring, which was similar to that from other methods: self report 100%, IQR 100 to 100; VAS 100%, IQR 95 to 100; simple tablet count 98%, IQR 89 to 100. Median total adherence in patients taking <80% of medication was significantly lower by electronic monitoring (69%, IQR 44 to 74) than by other methods: self report 100%, IQR 100 to 100; VAS 100%, IQR 95 to 100; and simple tablet count 90%, IQR 78 to 100 (all p<0.0001). Sensitivities of self report (10%), VAS (17%), and simple tablet count (50%) were all low for detecting suboptimal medicine intake. Self report, VAS, and simple tablet counts are insensitive as predictors of suboptimal medicine usage in PD. How patients take their medicines influences interpretation of the therapy response and consequent management decisions, with implications for clinical trial analysis and clinical practice.Keywords
This publication has 24 references indexed in Scilit:
- Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levelsPreventive Medicine, 2005
- Drug adherence in Parkinson's diseaseMovement Disorders, 2004
- Compliance with tricyclic antidepressants: the value of four different methods of assessmentBritish Journal of Clinical Pharmacology, 2000
- Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled studyMovement Disorders, 1998
- Noncompliance and treatment failure in children with asthmaJournal of Allergy and Clinical Immunology, 1996
- Role of Patient Compliance in Clinical PharmacokineticsClinical Pharmacokinetics, 1994
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Patient compliance and the conduct and interpretation of therapeutic trialsControlled Clinical Trials, 1987
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- Information, compliance and side‐effects: a study of patients on antidepressant medication.British Journal of Clinical Pharmacology, 1984